Cencora Total Current Liabilities 2010-2024 | COR
Cencora total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
- Cencora total current liabilities for the quarter ending September 30, 2024 were $52.974B, a 13.23% increase year-over-year.
- Cencora total current liabilities for 2023 were $48.831B, a 12.31% increase from 2022.
- Cencora total current liabilities for 2022 were $43.478B, a 5.12% increase from 2021.
- Cencora total current liabilities for 2021 were $41.359B, a 22.17% increase from 2020.
| Cencora Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $48,831 |
| 2022 | $43,478 |
| 2021 | $41,359 |
| 2020 | $33,853 |
| 2019 | $29,581 |
| 2018 | $27,870 |
| 2017 | $26,818 |
| 2016 | $25,280 |
| 2015 | $21,578 |
| 2014 | $17,250 |
| 2013 | $14,871 |
| 2012 | $11,266 |
| 2011 | $10,875 |
| 2010 | $9,906 |
| 2009 | $9,480 |
| Cencora Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024-06-30 | $52,974 |
| 2024-03-31 | $49,762 |
| 2023-12-31 | $50,773 |
| 2023-09-30 | $48,831 |
| 2023-06-30 | $46,783 |
| 2023-03-31 | $45,071 |
| 2022-12-31 | $44,761 |
| 2022-09-30 | $43,478 |
| 2022-06-30 | $43,154 |
| 2022-03-31 | $42,798 |
| 2021-12-31 | $41,614 |
| 2021-09-30 | $41,359 |
| 2021-06-30 | $39,590 |
| 2021-03-31 | $32,996 |
| 2020-12-31 | $35,044 |
| 2020-09-30 | $33,853 |
| 2020-06-30 | $30,632 |
| 2020-03-31 | $32,112 |
| 2019-12-31 | $30,630 |
| 2019-09-30 | $29,581 |
| 2019-06-30 | $28,789 |
| 2019-03-31 | $29,212 |
| 2018-12-31 | $29,352 |
| 2018-09-30 | $27,870 |
| 2018-06-30 | $28,100 |
| 2018-03-31 | $28,094 |
| 2017-12-31 | $26,740 |
| 2017-09-30 | $26,818 |
| 2017-06-30 | $25,751 |
| 2017-03-31 | $25,531 |
| 2016-12-31 | $25,543 |
| 2016-09-30 | $25,280 |
| 2016-06-30 | $23,997 |
| 2016-03-31 | $23,771 |
| 2015-12-31 | $24,024 |
| 2015-09-30 | $21,578 |
| 2015-06-30 | $21,117 |
| 2015-03-31 | $20,226 |
| 2014-12-31 | $20,805 |
| 2014-09-30 | $17,250 |
| 2014-06-30 | $16,339 |
| 2014-03-31 | $16,500 |
| 2013-12-31 | $15,829 |
| 2013-09-30 | $14,871 |
| 2013-06-30 | $12,442 |
| 2013-03-31 | $12,043 |
| 2012-12-31 | $11,436 |
| 2012-09-30 | $11,266 |
| 2012-06-30 | $10,951 |
| 2012-03-31 | $10,915 |
| 2011-12-31 | $11,301 |
| 2011-09-30 | $10,875 |
| 2011-06-30 | $10,008 |
| 2011-03-31 | $9,950 |
| 2010-12-31 | $9,641 |
| 2010-09-30 | $9,906 |
| 2010-06-30 | $9,487 |
| 2010-03-31 | $9,426 |
| 2009-12-31 | $9,243 |
| 2009-09-30 | $9,480 |
| 2009-06-30 | $8,587 |
| 2009-03-31 | $8,478 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $48.948B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $98.015B | 12.16 |
| DiDi Global (DIDIY) | China | $23.622B | 0.00 |
| ICON (ICLR) | Ireland | $17.731B | 15.79 |
| Natera (NTRA) | United States | $16.587B | 0.00 |
| Viatris (VTRS) | United States | $15.469B | 4.76 |
| Avantor (AVTR) | United States | $15.375B | 23.05 |
| Revvity (RVTY) | United States | $14.905B | 25.89 |
| BioMerieux (BMXMF) | France | $13.087B | 0.00 |
| CochLear (CHEOY) | Australia | $12.590B | 0.00 |
| Solventum (SOLV) | United States | $12.509B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.276B | 31.77 |
| Charles River Laboratories (CRL) | United States | $11.014B | 21.28 |
| Doximity (DOCS) | United States | $10.815B | 64.01 |
| HealthEquity (HQY) | United States | $8.629B | 46.83 |
| Sonic Healthcare (SKHHY) | Australia | $8.542B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $7.043B | 32.79 |
| Life Times (LTH) | United States | $5.170B | 34.22 |
| Sotera Health (SHC) | United States | $4.557B | 24.38 |
| Organon (OGN) | United States | $4.131B | 4.17 |
| Surgery Partners (SGRY) | United States | $3.859B | 42.76 |
| BrightSpring Health Services (BTSG) | United States | $3.408B | 72.48 |
| PACS (PACS) | United States | $3.251B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.620B | 0.00 |
| Concentras Parent (CON) | United States | $2.500B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.337B | 0.00 |
| Premier (PINC) | United States | $2.292B | 11.44 |
| GeneDx Holdings (WGS) | United States | $2.137B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.856B | 48.90 |
| Teladoc Health (TDOC) | United States | $1.589B | 0.00 |
| Progyny (PGNY) | United States | $1.499B | 26.37 |
| Pediatrix Medical (MD) | United States | $1.353B | 13.24 |
| Establishment Labs Holdings (ESTA) | $1.292B | 0.00 | |
| CareDx (CDNA) | United States | $1.268B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.104B | 7.49 |
| Embecta (EMBC) | United States | $0.897B | 5.98 |
| InnovAge Holding (INNV) | United States | $0.813B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.757B | 0.00 |
| SBC Medicals (SBC) | United States | $0.706B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.469B | 0.00 |
| DocGo (DCGO) | United States | $0.409B | 15.38 |
| Enhabit (EHAB) | United States | $0.397B | 34.30 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.373B | 0.00 |
| LifeMD (LFMD) | United States | $0.252B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.225B | 0.00 |
| ModivCare (MODV) | United States | $0.221B | 12.05 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| Biodesix (BDSX) | United States | $0.199B | 0.00 |
| Nutex Health (NUTX) | United States | $0.160B | 0.00 |
| MultiPlan (MPLN) | United States | $0.137B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.129B | 0.00 |
| So-Young (SY) | China | $0.089B | 21.63 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.055B | 0.00 |
| OncoCyte (OCX) | United States | $0.048B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.11 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Oncology Institute (TOI) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |